Introduction & Final Programme
Demographics
Photo Album
Posters
General Information
Venue & Travel
>Sponsors & Exhibitors
Contacts
Sponsors and Exhibitors
Sigma-Aldrich is a global supplier of leading RNA interference (RNAi) tools including siRNA through Sigma-Proligo and the comprehensive MISSION™ shRNA library through participation in The RNAi Consortium (TRC). As a key licensed supplier of siRNA and expert in high quality custom DNA and RNA oligonucleotide synthesis, our goal is to provide innovative products to meet your functional genomics and gene silencing research needs. The MISSION shRNA library of The RNAi Consortium, developed by the Broad Institute of MIT and Harvard, is a pre-cloned collection targeted against annotated human and mouse genes enabling scientists to elucidate gene function. For further details of the above products please visit www.sigma-aldrich.com/rnai.
Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 35 countries and has over 6,800 employees providing excellent service worldwide. We are committed to accelerating Customers’ success through leadership in Life Science, High Technology and Service.
Discover the latest innovations in RNA analysis from Ambion, The RNA Company. Ambion is a market leader in the development and supply of innovative RNA-based life science research and molecular biology products. Ambion offers a wide range of products for the isolation, stabilization, synthesis, detection, and quantitation of RNA including kits for RNA isolation, amplification, RT-PCR, premade Northerns, RNAs and cDNAs, siRNA, and most recently miRNA.
Ambion has developed innovative siRNA and miRNA tools to induce RNAi and make the technique accessible to new users. Along with the development of these siRNA and miRNA tools, Ambion has become an information resource for all RNAi researchers and now offers Cenix designed siRNA to human, rat, and mouse genomes plus custom synthesized siRNA. We are also the market leader in miRNA technology, providing complete miRNA solutions.
Exiqon is a leading supplier of high-value gene expression analysis products for the life sciences, research and drug discovery industries. Exiqon’s rapidly growing product offerings integrate innovative chemistries with web-based software tools to help scientists achieve rapid and reliable results. Exiqon markets its products directly on www.exiqon.com, or through distributors, and partners its proprietary Locked Nucleic Acids (LNA) and Anthraquinone (AQ) technologies through industry leaders. Exiqon is located in the Medicon Valley area of Copenhagen, Denmark.
Our miRCURY™ product line for microRNA research includes :
miRCURY™ Array – profile your microRNAs (slides and ready-to-spot oligonucleotide sets)
miRCURY™ Detection – detect your microRNAs by in situ hyb or Northern blotting
miRCURY™ Knockdown – knockdown your microRNAs for functional analysis
miRCURY™ Real-Time PCR – quantitate your microRNAsPlease visit our web-site at www.exiqon.com.
MWG Biotech AG (www.mwg-biotech.com) is an international provider of DNA sequencing and DNA/siRNA synthesis products and services for academic and industrial research from production sites in Germany, the US, and India. With strong customer orientation, fast service and high quality products the company creates the platform for success in the life sciences today and for a better life tomorrow.
Applied Biosystems serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services.
We provide a comprehensive, integrated workflow for gene expression enabling researchers to meet the challenges of Functional Genomics and Gene Signature Profiling.
Applied Biosystems offers Expression Array Technology and MicroRNA Profiling Technology for Target Identification in Human, Mouse and Rat. Furthermore, Applied Biosystems has developed TaqMan® MicroRNA Assays for quick and accurate real-time PCR quantitation.
Integrated DNA Technologies, Inc. (IDT) is the largest supplier of custom nucleic acids in the U.S. Serving the areas of academic research, biotechnology, and pharmaceutical development, IDT’s primary business is the manufacturing of DNA and RNA oligonucleotides (oligos) for research applications.
In addition, IDT is a leading developer of novel technologies that improve the efficacy of biomedical research, and that raise the standard and availability of the bioinformatics tools needed to support these research activities.
Supporting IDT’s mission to advance research in nucleic acid-based technologies, the staff at IDT combine expertise in synthetic chemistry, biophysics, molecular biology, bioinformatics and engineering. Basic product offerings include DNA oligos, RNA oligos, and over a hundred chemical modifications, ranging from short single-stranded oligos to 10,000 base pair synthetic genes. IDT products support DNA sequencing, DNA amplification, SNP detection, microarray analysis, expression profiling, gene quantification, and functional genomics. IDT scientists have developed novel methods for gene silencing and offer specialized RNAi, ddRNAi and antisense reagents.
For almost twenty years, IDT’s development has been guided by its uncompromising approach to quality, its belief in the value of good service, and its determination to minimize cost. Currently, over 60,000 customers worldwide turn to IDT to fulfill their oligo requirements.
Founded in 1987 by Joseph Walder, M.D., PhD (then a Professor of Biochemistry at the University of Iowa), Integrated DNA Technologies, Inc. has grown by an average of over 50% every year during the past 10 years, to where it is now synthesizing and shipping 15,000 – 25,000 oligos per day.
Today, IDT employs over 400 scientists and support personnel and routinely fulfills oligo orders that range from single primers to large projects comprising hundreds of thousands of oligonucleotides; IDT has the ability to rapidly ramp up production to meet any size order quickly without compromising quality.
QIAGEN N.V., a Netherlands holding company with subsidiaries in Germany, the United States, Japan, the United Kingdom, Switzerland, France, Italy, Australia, Norway, Austria, Canada, Sweden, and the Netherlands believes it is the world's leading provider of innovative enabling technologies and products for the separation, purification, and handling of nucleic acids and proteins. QIAGEN's products are sold in more than 42 countries throughout the world to academic research markets and to leading pharmaceutical and biotechnology companies.
For RNAi, QIAGEN provides a comprehensive range of products and services that cover the entire workflow from siRNA design and synthesis to exceptionally efficient transfection and ready-to-use downstream assays. QIAGEN uses the most advanced technologies possible including the innovative HiPerformance siRNA Design Algorithm which incorporates a neural-network–based design algorithm licensed from Novartis and QIAGEN’s proprietary homology analysis tool. This optimal combination of design and homology analysis ensures that siRNA is both potent and specific, providing high knockdown with minimal risk of nonspecific effects. Predesigned siRNAs for every human, mouse, and rat gene are available at the GeneGlobe™ Web portal (www.qiagen.com/GeneGlobe). QIAGEN’s latest RNAi offerings include the first-ever set of functionally tested kinase siRNAs for faster screening and maximum positive hits. To find out more about world-class RNAi solutions you can rely on, visit www.qiagen.com/siRNA.
[Trademarks: QIAGEN®, GeneGlobe™ (QIAGEN Group). siRNA technology licensed to QIAGEN is covered by various patent applications, owned by the Massachusetts Institute of Technology, the Carnegie Institute of Washington, Alnylam Corporation, and others]
Tecan (www.tecan.com) is a leading player in the Life Sciences supply industry that specializes in the development, production, and distribution of solutions enabling the discovery of pharmaceutical substances, as well as for genomics, proteomics, and diagnostics. Through its subsidiary REMP (www.remp.com) Tecan is a leading supplier of compound and sample storage, managerial and logistic solutions. Tecan clients are leading pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries.
The ACEA Biosciences RT-CES™ system utilizes revolutionary biosensor technology for label-free, real-time monitoring of cell based assays. The core of the system is the microelectronic cell sensor arrays integrated into the bottom of our microtiter plates which provide continuous, quantitative information about the biological status of attached cells. Any changes to cell number, size, morphology, or attachment quality will be detected in real-time without the use of reporter reagents. Proven assays include:
- Receptor activation (GPCR, RTK, etc.)
- Adhesion
- Compound mediated cytotoxicity
- Cell mediated cytotoxicity (ADCC, NK, etc.)
- Allergen Response
The integrated software allows data to be collected and saved automatically as often as every minute over virtually any time period. RT-CES is ideal for drug discovery and research applications involving cancer research, receptor/ligand interaction, cytotoxicity, apoptosis, and toxicology. Available in both 16 and 96-well multi-plate formats.
Perbio Science as an umbrella for Dharmacon
To life science researchers using RNA interference, Dharmacon is recognized as the world’s leading siRNA supplier and RNAi technology leader providing:
• Sophisticated siRNA design for reproducible gene silencing results
• siRNA reagents to silence any human, mouse or rat gene
• Best-in-industry technical support by expert scientists with in-depth RNAi knowledge
• Innovative siRNA delivery and experimental control products designed to improve experimental success
• Custom RNA and siRNA synthesis for specialized applications
• Patented 2’-ACE? RNA synthesis chemistryThis is a general overview of the most important Dharmacon product lines, for more specific product information, go to www.perbio.com or www.dharmacon.com.
The Journal of RNAi and Gene Silencing will publish high-quality peer-reviewed articles addressing the biology and application of RNA interference and gene silencing in all systems. The Journal aims at providing an efficient route to fast-track publication, within 10-12 weeks of manuscript submission if accepted. Furthermore, manuscripts will be made available online in their final form generally within two weeks of acceptance.
The Journal will be primarily published online but on sufficient demand for printed version journal hard copies may also be provided to individuals and institutions.
Manuscripts in the following categories will be considered for publication: reviews and mini-reviews, research articles and short research reports, new methods and technologies, opinions on previously published literature, letters to the editor, meeting reports and commercial, patent and product news.
The Journal of Molecular and Genetic Medicine will publish high-quality peer-reviewed articles addressing most aspects of molecular and genetic biomedical research. The Journal aims at providing an efficient route to fast-track publication, within 10-12 weeks of manuscript submission if accepted. Furthermore, manuscripts will be made available online in their final form generally within two weeks of acceptance.
The Journal will be primarily published online but on sufficient demand for printed version journal hard copies may also be provided to individuals and institutions.
Manuscripts in the following categories will be considered for publication: reviews and mini-reviews, research articles and short research reports, new methods and technologies, opinions on previously published literature and letters to the editor, meeting reports and commercial, patent and product news.
The Journal will accept manuscripts in most areas of molecular and genetic medicine – both basic and applied. Keeping in view the considerable health-related problems faced by the developing nations, particular consideration will be given to articles on applied biomedical issues of the developing world, especially, research focusing on malaria, HIV/AIDS, viral hepatitis and microbial diseases.
Keynote Speakers
Prof David Baulcombe, FRS
The Sainsbury Laboratory
John Innes Centre
Norwich, UK.
Prof Ronald Plasterk
The Hubrecht Laboratory
Netherlands Institute for Developmental Biology Utrecht, The Netherlands.
We are most grateful to the following societies for advertising this conference:
Royal Society of Chemistry
AllConferences.com
The America Society for Biochemistry and Molecular Biology
British Biochemical Society
Portuguese Biochemical Society
The Romanian Society of Biochemistry and Molecular Biology
The RNA Society
EURIT: European Union for RNA Interference Technology
The RNA Society of North Carolina
Slovenian Biochemical Society
Corporate Sponsor
Delegate Bag and
Badge
Sponsors
Exhibitors
Sponsoring
Publications
© Copyright by Library Publishing Media, Oxford, UK. All rights reserved.
http://www.LibPubMedia.co.uK